Robert E. Waltermire, Senior VP, Chief Pharma Development at MADRIGAL PHARMACEUTICALS, INC. (MDGL), sold 4,000 shares at $232.00 ($942K) on 2023-12-14, disclosed to the SEC on 2023-12-18.
Open-market sale of $942k MDGL by Senior VP, Chief Pharma Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $232.00 | 1,000 | $232K | 24.6% |
| 2 | $233.00 | 1,000 | $233K | 24.7% |
| 3 | $236.00 | 1,000 | $236K | 25.1% |
| 4 | $241.00 | 1,000 | $241K | 25.6% |
| Total | $235.50 avg | 4,000 | $942K | 100% |
| Filing → |
| MDGL | SELL | 2025-01-27 | $35K | — | Filing → |
| MDGL | SELL | 2025-01-17 | $242K | — | Filing → |
| MDGL | SELL | 2024-06-18 | $532K | — | Filing → |